Alkermes (ALKS) experienced a significant stock price increase of 5.00%, reaching $31.72 per share with a trading volume of 928,667 shares and a turnover rate o
Ironwood Pharmaceuticals (IRWD) recently experienced a significant stock price drop of 5.20%, bringing its share price to $3.58. The trading volume reached 431,
Ironwood Pharmaceuticals (IRWD) experienced a notable stock price increase of 5.20%. The stock is currently trading at $4.56 per share with a trading volume of
Dec 18, 2024 / 09:20PM GMTOperator Good afternoon. Welcome to cbdMD Inc.'s September 30, 2024 fourth fiscal 2024 quarter and fiscal 2024 earnings call and updat
Sonoma Pharmaceuticals, Inc. (SNOA) saw a significant stock price increase of 5.00%, reaching $2.94 per share. The trading volume was 38,078 shares with a turno
Shares of Intuitive Surgical, Inc. ISRG rose sharply in today's pre-market trading as the company posted better-than-expected third-quarter financial results.
...
Total Net Sales: $5.1 million for Q3 FY2024, a 15% decrease from $6.1 million in Q3 FY2023, but an 18% sequential increase.E-commerce Sales: $3.9 million for Q
Connecticut-based Rallybio Corporation (RLYB), a clinical-stage biotechnology company is up over 90 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.
Connecticut-based Rallybio Corporation (RLYB), a clinical-stage biotechnology company is up over 90 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Humble & Fume Names New CEO Humble & Fume Inc. (CSE: HMBL) (OTCQX: HUMBF) has named chairman of the board Jakob Ripshtein to be its new CEO. He replaces Joel Toguri, who is stepping down to pursue other career opportunities.
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II medical device.